Skip to main content

Quality Measure Development

Senior Asian Couple Business Audience


Inpatient Psychiatric Facility (IPF) Outcome and Process Measure Development Project

Winterstein AG, Bussing R, Goodin A, Xu D, Keenan M, Turner K, Meyyur V, Duseja R, Campbell K. Development and validation of an administrative claims-based measure for all-cause 30-day risk-standardized readmissions after discharge from inpatient psychiatric facilities [published ahead of print, December 6, 2019]. Medical Care. doi: 10.1097/MLR.0000000000001275.

Keenan M, Turner K, McKay P, Hall M, Wright S, Yang T, Stanback B, Bussing R, Winterstein AG, and Campbell K. Methodology Report: Medication Continuation Following Inpatient Psychiatric Discharge – Version 1.0. [Prepared by HSAG for CMS.] Baltimore, MD: US Department of Health and Human Services; March 2017. Available at: Accessed February 21, 2020.

Winterstein A, Bussing R, Keenan M, Pace K, Turner K, Xu D, Yang T, Zambrano D, and Campbell K. Inpatient Psychiatric Facility All-Cause Unplanned Readmission Measure, Version 1.0: Final Technical Report. [Prepared by HSAG for CMS.] Baltimore, MD: US Department of Health and Human Services; February 16, 2016. Available at: Accessed February 21, 2020.

Maintenance and Development of Medication Measures Special Innovation Project

Campbell K, Winterstein A. Development of robust quality measures for identifying and preventing adverse drug events. Presented at: CMS Grand Rounds; April 26, 2012; Baltimore, MD.

Bodkin N, Campbell K. Medication measures focusing on safety and effectiveness: From concept to endorsement. Presented at: QualityNet Conference; December 15, 2011; Baltimore, MD.